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the level of known risk factors of CVD. Nevertheless,
mobile screening unit is a good method for increasing
the awareness of the public.
http://dx.doi:10.1016/j.jsha.2012.06.252
Two years follow up of patients who underwent
trans-catheter aortic valve implantation at Prince
Sultan Cardiac Center (TAVI)
Saeed Al Ahmari, Mohammed Al Otabi, Saad Al
Kasab, Adel Tash, Moheeb Al Abdullah, Husien Al
Amri
Objectives: We report our two years clinical, and
echo follow up of patients who underwent trans-apical
and trans-femoral TAVI.
Methods: All patients who underwent TAVI therapy
have been followed at six, 12, and 24 months, where clin-
ical, and echo evaluation have been obtained.
Results: Sixty-six pat were operated, with mean age
of 78.7 ± 9.3 y, 53% females, and 47% males. The mean
logistic Euro score was 21 ± 8. 55% of pat completed 2
years follow-up. Fourty-two pat received Edward Sapien
valve (25 trsna-apical, and 17 trans-femoral ), and 24 pat
received core valve. Thirty days mortality in Sapien valve
group was 11%, and 0% in Core valve group. CVA devel-
oped in 8% of the core valve group, and 7% of the Sapien
valve group. Complete heart block developed in 37.5 of
Core group, and 4.8% of the sapien group. Peripheral
arterial complications occurred in 12.5% of Core patients,
and 5.8% of Sapien patients. On follow up, patient’s
symptoms improved. The PG decreased from
88 ± 22 mmHg to 19 ± 7 mmHg, P < 0.0001, and the mitral
regurgitation (MR) severity grade decreased from
1.6 ± 1.1 to 0.9 ± 0.6, P < 0.001. Paravalvular leak was mild
in 15.2%, and moderate in 6.1% of patients.
Conclusion: TAVI is promising technique in treating
patients with severe AS with acceptable mortality rate.
There was significant improvement in patient’s symp-
toms, reduction in aortic gradient and reduction in MR
severity.
http://dx.doi:10.1016/j.jsha.2012.06.253
Routine invasive versus ischemia-guided strategy
in patients with acute inferior ST-elevation myo-
cardial infarction who received fibrinolytic ther-
apy: A prospective randomized controlled pilot
trial
Samah Abdul-Rahman, Wail Nammas, Adel
Gamal, Amr Adel, Tarek Zaki
Aims: We sought to compare a routine invasive strat-
egy of early coronary angiography and intended revascu-
larization, with an ischemia-guided strategy in patients
with acute inferior ST elevation myocardial infarction
(STEMI) who received fibrinolytic therapy.
Methods: We enrolled 60 consecutive patients with
acute inferior STEMI who received fibrinolytic therapy
within 6 h. Patients were randomly assigned to either a
routine invasive strategy in which coronary angiography
was performed within 48 h with intended revasculariza-
tion if eligible (Group A), or an ischemia-guided strategy
in which catheterization was based on the presence of
myocardial ischemia and viability as demonstrated by
stress myocardial perfusion imaging (Group B). Patients
were prospectively followed up for 6 months. The pri-
mary endpoint was a composite of cardiac death, recur-
rent myocardial infarction, recurrent ischemia or stroke
at 6-month follow-up. Total costs per patient were calcu-
lated over 6 months.
Results: The mean age of the whole series was
52 ± 9.8 years (15% females). The primary endpoint
occurred more frequently in group A as compared to
group B, however, the difference did not meet statistical
significance (36.7% versus 23.3%, respectively, p > 0.05).
The mean cost per patient at 6-month follow-up was sig-
nificantly higher in Group A as compared to that in
Group B ($4953.5 ± 3108.5 versus $2764.6 ± 2636.7, respec-
tively, p < 0.01).
Conclusions: In patients presenting with inferior
STEMI who received fibrinolytic therapy, a routine inva-
sive strategy with early coronary angiography and
intended revascularization, achieved a clinical outcome
similar to an ischemia-guided strategy; yet, at a signifi-
cantly higher cost.
http://dx.doi:10.1016/j.jsha.2012.06.254
Impact of chylothorax on the post operative out-
come after pediatric cardiovascular surgery
Sameh R. Ismail, Mohamed S. Kabbani, Hani K.
Najm, Ghassan A. Shaath, Abdulraouf M.Z. Jijeh
Background: Chylothorax is the accumulation of
chyle in the pleural cavity, usually develops after disrup-
tion of the thoracic duct along its intra-thoracic route. In
the majority of cases this rupture is secondary to trauma
(including cardio thoracic surgeries). Chylothorax is a
potentially serious complication after cardiovascular sur-
geries that require early diagnosis and adequate
management.
Methods: A retrospective study of all cases compli-
cated with chylothorax after pediatric cardiac surgery in
King Abdulaziz Cardiac Center between January 2007
and December 2009 was conducted. The study aim to
determine the risk factors, and the impact on the post
operative course.
Results: We have 1135 cases operated during the
study period, 57 cases (5%) were complicated with chylo-
thorax in the post operative period. The most common
surgeries complicated with chylothorax were the single
ventricle repair surgeries (Glenn-Fontan) 15 cases
(27%), followed by the arch repair cases 10 cases (18%),
the ventricular septal defect cases 10 cases (18%), the
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Atrioventricular septal defect cases 7 cases (12%), the
arterial switch cases 6 cases (11%), and others 8 cases
(14%). The ICU stay, the length of hospital stay and the
bypass time were significantly longer in the chylothorax
group, also the ventilation time, the inotropes duration
and number were higher in the chylothorax group.
Conclusion: Chylothorax after pediatric open heart
surgery is not an uncommon complication, it occurs more
commonly with single ventricle repair and aortic arch
repair surgeries, it has a significant impact on the post
operative course and post operative morbidity.
http://dx.doi:10.1016/j.jsha.2012.06.255
Is there an optimal intensive care management?
Following release of obstruction in neonates with
critical PS/ATR & IVS
Shawana Farooq Shaikh
Neonates with critical pulmonary stenosis or
complete pulmonary artesia and intact interventric-
ular septum represent wide range of pathological
findings in term of magnitude of hypoplasia of
the different right ventricular components.
Although available range of imaging modalities
enabled paediatric cardiologist to delineate, who
would benefit from interventional or surgical
release of critical pulmonary stenosis/atresia. The
post interventional or and after surgical release of
critical pulmonary stenosis/atresia challenges the
paediatric cardiac intensivist with various spectrum
of pathophysiological status.
Empirically we noticed that some neonates
recover and discharged from the intensive care unit
in 2–3 days, while others require longer intensive
care management and quite good number will stay
in the ICU much longer on prostaglandin infusion
and may require further intervention such as bal-
loon atrial septostomy, shunt or implantation of
PDA stent.
We have retrospectively evaluated these patients
in relation to pre and post operative/interventional
pathology/pathophysiology, age and general status
of patients before and after procedures and high-
lighting the intensive care physical and pharmaco-
logical actions.
http://dx.doi:10.1016/j.jsha.2012.06.256
Comparison of femoral closure devices with man-
ual compression in postcardiac catheterization
patients
Sulman Razzaq, Paul S. Gilmore, Robert F. Percy
Objective: The objective of our study was to com-
pare femoral closure devices to manual compression in
limiting vascular access complications at our center.
Methods: Data was obtained from computer data-
base for cardiac catheterizations done at University of
Florida, Jacksonville from 1st March 2002 to 29th Febru-
ary 2004. Vascular complications included groin bleeding,
hematoma (> 4 cm), retroperitoneal bleeding, AV fistula,
limb ischemia , pseudoaneurysm, infection and death
as a direct result of vascular complication. Hemostasis
technique was divided into three groups; Manual com-
pression, Sealant and Suture group.
Results: A total number of 3843 cases were per-
formed and all variables were similarly distributed
among three groups except for lesser GpIIb/IIIa inhibitor
use in sealant group. A total of 71 complications (1.85%)
were recorded. They included 33 bleeds, 12 Pseudoaneu-
rysms, 17 hematomas (> 4 cm), 4 retroperitoneal bleeds, 2
AV fistulae, 1 infection and 2 deaths. Overall, 9 complica-
tions occurred in Sealant group (0.85%), 4 in Suture
group (3.3%) and 58 (2.1%) in manual compression.
Logistic regression analysis showed that when GpIIb/IIIa
agents are not used, Sealant device is associated with less
vascular complications. (p = 0.008) However, with GpIIb/
IIIa agents there is no difference among closure devices
or manual compression (p = 0.074) with overall increase
in vascular complications.
Conclusions: Sealant closure devices are associated
with less vascular complications at our center when
GpIIb/IIIa agents were not used. However, with GPIIb/
IIIa inhibitors , there is no difference in the vascular com-
plications among the three groups.
http://dx.doi:10.1016/j.jsha.2012.06.257
Does negative calcium score exclude coronary
artery disease
Sumaya Al Helali, Mohammed Al Mehari, Kazem
Hameedullah, Samer Al Dulikan, Abdullah
Bafagih, Saeed Al Ahmari
Aim: We aimed to measure the coronary calcification
and investigate if negative coronary calcification excludes
coronary artery disease (CAD).
Methods: Clinically indicated patients were scanned
using 64 slice CCT to measure Agatston coronary calcifi-
cation score. CT coronary angiography( CTA) was per-
formed, and invasive coronary angiography (CA) was
performed when it is indicated.
Results: 2352 patients were scanned. 1152 patients
had negative calcium score (49%). The mean age was
52 ± 13.2 y, 65% males, & 35% females. Chest pain was
the indication in 80% of cases. There was 37% diabetic,
58% hypertensive, 23.6% hyperlipidemic, 13% smoker,
& 32% with family history of CAD.
The calcium score excludes CAD in 90% of patients as
confirmed by normal coronary CTA. In 10% of patients
who had negative calcium, coronary plaques were found
by CTA. CA was performed in 50% of those with negative
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